Complementary Healthcare Analysis - 2019-09-11

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Long/Short Equity, Healthcare, Biotech

Contributor Since 2017

Avisol Capital Partners runs the Total Pharma Tracker Seeking Alpha Marketplace service. This is managed by Dr Asok Dutta, BVScAH and Dr Udaya Kumar Maiya, MD Oncologist. The service offers end-to-end research on both investing and trading ideas everyday, and includes a 150-stock watchlist and two 40-stock model portfolios that are continuously tracked.

Dr Dutta is a retired veterinary surgeon. He has over 40 years experience in the industry. Dr Maiya is a well-known oncologist who has 30 years in the medical field, including as Medical Director of various healthcare institutions. Both doctors are also avid private investors. They are assisted by a number of finance professionals in developing this service.

If you want to check out our service, go here - https://seekingalpha.com/author/avisol-capital-partners/research

Disclaimer - we are not investment advisors.
Top Gainers
Company Market Cap Price Change% Volume
Mallinckrodt plc (MNK) 325.14M 3.88 84.76% 53,332,812
Teva Pharmaceutical Industries Limited (TEVA) 8.60B 8.13 9.27% 45,184,072
Endo International plc (ENDP) 613.24M 4.00 30.29% 24,347,826
Immunomedics, Inc. (IMMU) 3.07B 15.59 17.39% 6,540,035
Clovis Oncology, Inc. (CLVS) 324.84M 6.00 13.42% 4,749,332
Top Losers
Company Market Cap Price Change% Volume
Merit Medical Systems, Inc. (MMSI) 1.50B 27.98 -9.54% 3,588,370
Adverum Biotechnologies, Inc. (ADVM) 742.11M 11.59 -6.91% 1,830,814
Option Care Health, Inc. (BIOS) 2.27B 3.22 -6.40% 1,352,553
Zymeworks Inc. (ZYME) 1.03B 26.98 -6.58% 511,032
Nuvectra Corporation (NVTR) 31.79M 1.77 -5.35% 482,719
High volume stocks reaching new highs
Company Market Cap Price Change% Volume
Catalyst Pharmaceuticals, Inc. (CPRX) 674.49M 6.92 4.37% 2,763,090
Ardelyx, Inc. (ARDX) 390.18M 6.04 7.47% 2,638,146
High volume stocks reaching new lows
Company Market Cap Price Change% Volume
BioMarin Pharmaceutical Inc. (BMRN) 13.38B 73.59 2.31% 1,203,661
Regeneron Pharmaceuticals, Inc. (REGN) 30.36B 283.72 1.69% 1,159,889
Zafgen, Inc. (ZFGN) 24.84M 0.66 0.47% 1,026,276
Ligand Pharmaceuticals Incorporated (LGND) 1.75B 90.19 4.57% 617,796
Obalon Therapeutics, Inc. (OBLN) 9.88M 1.73 0.58% 523,457
Major Analyst Upgrades
Company Current Rating New Rating Analyst Current Price Target Price
AVEO Pharmaceuticals (AVEO) Neutral Buy HC Wainwright $0.92 $1.75
Bicycle Therapeutics (BCYC) Neutral Buy Goldman Sachs Group $7.03
Lexicon Pharmaceuticals (LXRX) Hold Buy Gabelli $1.72 $3.00
Major Analyst Downgrades
Company Current Rating New Rating Analyst Current Price Target Price
Consort Medical (CSRT) Hold Shore Capital GBX 742
Davita (DVA) Outperform Market Perform William Blair $61.66
Neurotrope (NTRP) Buy Neutral Janney Montgomery Scott $0.92
Major Insider Buys
Company Insider Name Insider Title Price Qty Value
Aldeyra Therapeutics, Inc. (ALDX) Clark David J Chief Medical Officer $5.06 5000 +$25,311
Catalent, Inc. (CTLT) Lucier Gregory T Dir $51.64 2000 +$103,280
Mirum Pharmaceuticals, Inc. (MIRM) Clements Ian SVP Finance, Communications $11.51 4000 +$46,039
Fischer Laurent Dir $10.60 4650 +$49,303
Peetz Christopher Pres, CEO $11.02 9070 +$99,938
Vig Pamela Chief Scientific Officer $10.97 1612 +$17,682
Organogenesis Holdings Inc. (ORGO) Avista Capital Managing Member Iv, LLC Dir, 10% $5.18 537000 +$2,782,529
Nussdorf Glenn H Dir, 10% $5.03 10000 +$50,274
Major Insider Sells
Company Insider Name Insider Title Price Qty Value
Arena Pharmaceuticals Inc (ARNA) Aurentz Vincent EVP, CBO $50.72 -65000 -$3,296,700
Spector Steven W EVP, GC, Sec $50.59 -44084 -$2,230,388
Biospecifics Technologies Corp (BSTC) Wegman Toby Dir, 10% $55.17 -10000 -$551,677
Emergent Biosolutions Inc. (EBS) Zoon Kathryn C Dir $56.12 -1509 -$84,692
Fibrogen Inc (FGEN) Kurkijarvi Kalevi Dir $40.95 -6000 -$245,723
Pfenex Inc. (PFNX) Lucy Patrick K. Chief Business Officer $8.00 -6000 -$48,021
Reata Pharmaceuticals Inc (RETA) Castellanos Elaine Principal Accounting Officer $85.00 -2000 -$170,000
Teva Pharmaceutical Industries Ltd (TEVA) Daniell Richard EVP, European Commercial $7.16 -333 -$2,384

Index Watch

NASDAQ Health CareINDEXNASDAQ: IXHC

image.png

iShares NASDAQ Biotechnology Index

NASDAQ: IBB

image.png

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.